PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 20734204-5 2011 Correlation analysis revealed that the concentrations of fasting serum insulin were positively correlated with IGF-1 (r = 0.443, P = 0.001) and Deltaheight standard deviation score (SDS; r = 0.500, P = 0.002) in <= 6-year-old SGA children, but only with Deltaweight SDS (r = 0.496, P = 0.030) in >6-year-old children. sds 182-185 insulin Homo sapiens 71-78 20061427-10 2010 Serum IGFBP-2 SDS in SGA young adults correlated positively with insulin sensitivity and negatively with fat mass SDS, insulin secretion (acute insulin response), fasting insulin, homeostasis model of assessment for insulin resistance, total cholesterol, triglycerides, and blood pressure SDS. sds 14-17 insulin Homo sapiens 65-72 20061427-10 2010 Serum IGFBP-2 SDS in SGA young adults correlated positively with insulin sensitivity and negatively with fat mass SDS, insulin secretion (acute insulin response), fasting insulin, homeostasis model of assessment for insulin resistance, total cholesterol, triglycerides, and blood pressure SDS. sds 14-17 insulin Homo sapiens 119-126 20061427-11 2010 The association between serum IGFBP-2 SDS and insulin sensitivity, blood pressure, total cholesterol, and triglyceride levels persisted after adjustment for known covariates including fat mass SDS. sds 38-41 insulin Homo sapiens 46-53 20061427-10 2010 Serum IGFBP-2 SDS in SGA young adults correlated positively with insulin sensitivity and negatively with fat mass SDS, insulin secretion (acute insulin response), fasting insulin, homeostasis model of assessment for insulin resistance, total cholesterol, triglycerides, and blood pressure SDS. sds 14-17 insulin Homo sapiens 119-126 20061427-10 2010 Serum IGFBP-2 SDS in SGA young adults correlated positively with insulin sensitivity and negatively with fat mass SDS, insulin secretion (acute insulin response), fasting insulin, homeostasis model of assessment for insulin resistance, total cholesterol, triglycerides, and blood pressure SDS. sds 14-17 insulin Homo sapiens 119-126 19158202-8 2009 IGFBP-1 SDS correlated significantly with insulin levels, systolic blood pressure SDS, and various lipid parameters. sds 8-11 insulin Homo sapiens 42-49 19158202-10 2009 In response to a given insulin level, children with the AA genotype had a significantly higher IGFBP-1 SDS compared to children with the GG genotype. sds 103-106 insulin Homo sapiens 23-30 9877256-10 1998 The percent overweight, percent body fat, waist girth and WHR/Ht SDS all correlated well with triglyceride (TG), alanine aminotransferase (ALT) and insulin in boys, whereas only waist girth and WHR/Ht SDS showed a close correlation with TG and insulin in girls. sds 65-68 insulin Homo sapiens 148-155 16960161-8 2006 Only in the 126 children who reduced their SDS-BMI did BP (8% and 12% decreases in systolic and diastolic BP, respectively), lipids (12% and 5% decreases in triacylglycerol and LDL cholesterol, respectively; 7% increase in HDL cholesterol), insulin (13% decrease), and HOMA-IR (17% decrease) improve significantly (P < 0.05). sds 43-46 insulin Homo sapiens 241-248 10890193-9 2000 The level of IGFBP-I SDS correlated negatively with fIGF-I SDS (r=-0.472, p=0.0008) and insulin (r=-0.365, p=0.0116). sds 21-24 insulin Homo sapiens 88-95 9347406-9 1997 Using partial correlation analysis in subjects subdivided according to sex and pubertal stages, log values of serum leptin and fasting insulin values, adjusted by age and SDS of BMI, correlated significantly with a weaker correlation in males than in females. sds 171-174 insulin Homo sapiens 135-142 32889482-10 2020 An IQR higher natural log transformed third trimester maternal bisphenol F urine concentration was associated with a 0.22 (95% CI 0.35-0.09) SDS lower non-fasting insulin concentration among boys. sds 141-144 insulin Homo sapiens 163-170 34485526-9 2021 IGF-1 SDS was negatively associated with insulin resistance in obese prepubertal boys, independent of other traditional cardiovascular disease risk markers. sds 6-9 insulin Homo sapiens 41-48 30641751-9 2019 Our results showed a significant association between insulin requirement and BMI SDS (r = 0.23, p = 0.02) and a significant association between insulin requirement and mean HbA1c (r = 0.59, p=<0.01). sds 81-84 insulin Homo sapiens 53-60 30641751-10 2019 A multivariable regression analysis of factors affecting BMI SDS showed that insulin requirement was an independent factor affecting BMI SDS. sds 61-64 insulin Homo sapiens 77-84 30641751-10 2019 A multivariable regression analysis of factors affecting BMI SDS showed that insulin requirement was an independent factor affecting BMI SDS. sds 137-140 insulin Homo sapiens 77-84 26887040-8 2016 RESULTS: At baseline, height-SDS was significantly related to IGF-1-SDS (beta-coefficient 0.68 95% confidence interval (95% CI)+-0.49; p=0.008) and leptin (beta-coefficient 0.042 95% CI+-0.030; p=0.008), but not to FGF-21 or insulin. sds 29-32 insulin Homo sapiens 225-232 24158774-8 2014 A longer duration of insulin pump therapy was associated with a lower BMI-SDS (r = -0.2375, p < 0.025). sds 74-77 insulin Homo sapiens 21-28 25001656-9 2014 Weight and length SD scores (SDS) were higher in subjects with elevated insulin levels (p=0.002). sds 29-32 insulin Homo sapiens 72-79 24197766-8 2014 After adjustment for metabolic control, center, and insulin treatment, BMI-SDS was significantly influenced by diabetes duration, age, and female gender. sds 75-78 insulin Homo sapiens 52-59 23860366-8 2013 Children in the highest IGF-I SDS tertile at baseline were the least insulin sensitive at baseline (p = 0.024) and 1 year (p = 0.006). sds 30-33 insulin Homo sapiens 69-76 24015040-6 2013 The body weight and BMI standard deviation scores (SDS) 15 yr after diagnosis were significantly higher among the patients with low C-peptide levels (weight SDS, P = 0.012; BMI SDS, P = 0.044). sds 51-54 insulin Homo sapiens 132-141 24015040-6 2013 The body weight and BMI standard deviation scores (SDS) 15 yr after diagnosis were significantly higher among the patients with low C-peptide levels (weight SDS, P = 0.012; BMI SDS, P = 0.044). sds 157-160 insulin Homo sapiens 132-141 22564668-5 2012 RESULTS: More gain in weight for length SDS in the first 3 months of life was significantly associated with an increased number of MetS components [odds ratio (OR) = 1.34], prevalence of low high-density lipoprotein cholesterol (OR = 1.49), prevalence of MetS (OR = 2.51), increased C-reactive protein levels, and lower insulin sensitivity (P = 0.007) at the age of 21 yr. Low birth weight SDS was associated with lower insulin sensitivity (P = 0.036), but low birth weight SDS and adult IGF-I SDS were not significantly associated with any of the MetS components or MetS prevalence at 21 yr. sds 40-43 insulin Homo sapiens 320-327 22564668-5 2012 RESULTS: More gain in weight for length SDS in the first 3 months of life was significantly associated with an increased number of MetS components [odds ratio (OR) = 1.34], prevalence of low high-density lipoprotein cholesterol (OR = 1.49), prevalence of MetS (OR = 2.51), increased C-reactive protein levels, and lower insulin sensitivity (P = 0.007) at the age of 21 yr. Low birth weight SDS was associated with lower insulin sensitivity (P = 0.036), but low birth weight SDS and adult IGF-I SDS were not significantly associated with any of the MetS components or MetS prevalence at 21 yr. sds 40-43 insulin Homo sapiens 420-427